au.\*:("RAJKUMAR, S. Vincent")
Results 1 to 25 of 178
Selection :
Multiple myeloma: 2012 update on diagnosis, risk-stratification, and managementRAJKUMAR, S. Vincent.American journal of hematology. 2012, Vol 87, Num 1, pp 79-88, issn 0361-8609, 10 p.Article
Multiple Myeloma: Spotlight ReviewsRAJKUMAR, S. Vincent.Leukemia. 2008, issn 0887-6924, 148 p., NSSerial Issue
Thalidomide: Tragic past and promising futureRAJKUMAR, S. Vincent.Mayo Clinic proceedings. 2004, Vol 79, Num 7, pp 899-903, issn 0025-6196, 5 p.Article
Multiple myeloma: 2011 update on diagnosis, risk-stratification, and managementRAJKUMAR, S. Vincent.American journal of hematology. 2011, Vol 86, Num 1, pp 57-65, issn 0361-8609, 9 p.Article
Role of autologous and allogeneic stem cell transplantation in myelomaBENSINGER, Wl.Leukemia. 2008, issn 0887-6924, R51-R57, NSArticle
Why not start with thalidomide?LOPRINZI, Charles; RAJKUMAR, S. Vincent.Journal of clinical oncology. 2003, Vol 21, Num 11, pp 2211-2214, issn 0732-183X, 4 p.Article
Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent diseaseRAJKUMAR, S. Vincent.Seminars in hematology. 2003, Vol 40, Num 4, pp 17-22, issn 0037-1963, 6 p., SUP4Conference Paper
Update on risk stratification and treatment of newly diagnosed multiple myeloma : PIH: Understanding the Pathogenesis and the Evolving Treatment Paradigm for Multiple Myeloma in the Era of Novel AgentsKAPOOR, Prashant; RAJKUMAR, S. Vincent.International journal of hematology. 2011, Vol 94, Num 4, pp 310-320, issn 0925-5710, 11 p.Article
Renal manifestations of plasma cell disordersLEUNG, Nelson; RAJKUMAR, S. Vincent.American journal of kidney diseases. 2007, Vol 50, Num 1, pp 155-165, issn 0272-6386, 11 p.Article
Development of Early Treatment Strategies for High-Risk Myeloma Precursor Disease in the FutureLANDGREN, Ola; RAJKUMAR, S. Vincent.Seminars in hematology. 2011, Vol 48, Num 1, pp 66-72, issn 0037-1963, 7 p.Article
Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesisLANDGREN, O; WEISS, B. M.Leukemia. 2008, issn 0887-6924, R29-R35, NSArticle
Management of Newly Diagnosed MyelomaRAJKUMAR, S. Vincent; PALUMBO, Antonio.Hematology/oncology clinics of North America. 2007, Vol 21, Num 6, issn 0889-8588, ix-x, 1141-1156Article
Treatment of multiple myeloma : An emphasis on new developmentsKYLE, Robert A; RAJKUMAR, S. Vincent.Annals of medicine (Helsinki). 2006, Vol 38, Num 2, pp 111-115, issn 0785-3890, 5 p.Article
Multiple myeloma : Diagnosis and treatmentRAJKUMAR, S. Vincent; KYLE, Robert A.Mayo Clinic proceedings. 2005, Vol 80, Num 10, pp 1371-1382, issn 0025-6196, 12 p.Article
Thalidomid: Current role in the treatment of non-plasma cell malignanciesKUMAR, Shaji; WITZIG, Thomas E; RAJKUMAR, S. Vincent et al.Journal of clinical oncology. 2004, Vol 22, Num 12, pp 2477-2488, issn 0732-183X, 12 p.Article
Multiple myelomaKYLE, Robert A; RAJKUMAR, S. Vincent.Blood. 2008, Vol 111, Num 6, pp 2962-2972, issn 0006-4971, 11 p.Article
Treatment of newly diagnosed myelomaPALUMBO, A; RAJKUMAR, S. V.Leukemia. 2008, issn 0887-6924, R43-R50, NSArticle
From Myeloma Precursor Disease to Multiple Myeloma: New Diagnostic Concepts and Opportunities for Early Intervention : Multiple MyelomaLANDGREN, Ola; KYLE, Robert A; RAJKUMAR, S. Vincent et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1243-1252, issn 1078-0432, 10 p.Article
Prevalence of Monoclonal Gammopathy of Undetermined Significance: A Systematic ReviewWADHERA, Rishi K; RAJKUMAR, S. Vincent.Mayo Clinic proceedings. 2010, Vol 85, Num 10, pp 933-942, issn 0025-6196, 10 p.Article
Multiple myelomaKYLE, Robert A; RAJKUMAR, S. Vincent.The New England journal of medicine. 2004, Vol 351, Num 18, pp 1860-1873, issn 0028-4793, 14 p.Article
Angiogenesis in Waldenstrom's macroglobulinemiaRAJKUMAR, S. Vincent; HAYMAN, Suzanne; GREIPP, Philip R et al.Seminars in oncology. 2003, Vol 30, Num 2, pp 262-264, issn 0093-7754, 3 p.Article
Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders : Diagnosis and treatmentRAJKUMAR, S. Vincent; DISPENZIERI, Angela; KYLE, Robert A et al.Mayo Clinic proceedings. 2006, Vol 81, Num 5, pp 693-703, issn 0025-6196, 11 p.Article
Pathogenesis of myeloma bone diseaseROODMAN, G. D.Leukemia. 2008, issn 0887-6924, R36-R42, NSArticle
Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma : emphasis on risk factors for progressionKYLE, Robert A; RAJKUMAR, S. Vincent.British journal of haematology. 2007, Vol 139, Num 5, pp 730-743, issn 0007-1048, 14 p.Article
Monoclonal gammopathy of undetermined significanceKYLE, Robert A; RAJKUMAR, S. Vincent.British journal of haematology. 2006, Vol 134, Num 6, pp 573-589, issn 0007-1048, 17 p.Article